Articles with public access mandates - Aliccia Bollig-FischerLearn more
Available somewhere: 34
Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer
G Liu, A Bollig-Fischer, B Kreike, MJ van de Vijver, J Abrams, SP Ethier, ...
Oncogene 28 (50), 4491-4500, 2009
Mandates: US National Institutes of Health
Genes associated with prostate cancer are differentially expressed in African American and European American men
IJ Powell, G Dyson, S Land, J Ruterbusch, CH Bock, S Lenk, M Herawi, ...
Cancer epidemiology, biomarkers & prevention 22 (5), 891-897, 2013
Mandates: US National Institutes of Health
Transforming properties of 8p11-12 amplified genes in human breast cancer
ZQ Yang, G Liu, A Bollig-Fischer, CN Giroux, SP Ethier
Cancer research 70 (21), 8487-8497, 2010
Mandates: US National Institutes of Health
Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells
A Thakur, Y Sun, A Bollig, J Wu, H Biliran, S Banerjee, FH Sarkar, DJ Liao
Clinical cancer research 14 (14), 4427-4436, 2008
Mandates: US National Institutes of Health
Expression profile of microRNAs in c-Myc induced mouse mammary tumors
Y Sun, J Wu, S Wu, A Thakur, A Bollig, Y Huang, D Joshua Liao
Breast cancer research and treatment 118, 185-196, 2009
Mandates: US National Institutes of Health
Intronic non-CG DNA hydroxymethylation and alternative mRNA splicing in honey bees
P Cingolani, X Cao, RS Khetani, CC Chen, M Coon, A Sammak, ...
BMC genomics 14, 1-15, 2013
Mandates: US National Institutes of Health
Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity
B Bao, C Mitrea, P Wijesinghe, L Marchetti, E Girsch, RL Farr, JL Boerner, ...
Scientific reports 7 (1), 44125, 2017
Mandates: US National Institutes of Health
Racial disparities in the molecular landscape of cancer
EI Heath, F Lynce, J Xiu, A Ellerbrock, SK Reddy, E Obeid, SV Liu, ...
Anticancer Research 38 (4), 2235-2240, 2018
Mandates: US National Institutes of Health
Racial diversity of actionable mutations in non–small cell lung cancer
A Bollig-Fischer, W Chen, SM Gadgeel, AS Wenzlaff, ML Cote, ...
Journal of Thoracic Oncology 10 (2), 250-255, 2015
Mandates: US National Institutes of Health
Amyloid-beta neuroprotection mediated by a targeted antioxidant
CR Giordano, LJ Terlecky, A Bollig-Fischer, PA Walton, SR Terlecky
Scientific reports 4 (1), 4983, 2014
Mandates: US National Institutes of Health
Methylation‐associated silencing of SFRP1 with an 8p11‐12 amplification inhibits canonical and non‐canonical WNT pathways in breast cancers
ZQ Yang, G Liu, A Bollig‐Fischer, R Haddad, AL Tarca, SP Ethier
International journal of cancer 125 (7), 1613-1621, 2009
Mandates: US National Institutes of Health
Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics
A Bollig-Fischer, SK Michelhaugh, P Wijesinghe, G Dyson, A Kruger, ...
Oncotarget 6 (16), 14614, 2015
Mandates: US National Institutes of Health
Modeling time-dependent transcription effects of HER2 oncogene and discovery of a role for E2F2 in breast cancer cell-matrix adhesion
A Bollig-Fischer, L Marchetti, C Mitrea, J Wu, A Kruger, V Manca, ...
Bioinformatics 30 (21), 3036-3043, 2014
Mandates: US National Institutes of Health
Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer
JM Madden, KL Mueller, A Bollig-Fischer, P Stemmer, RR Mattingly, ...
Breast cancer research and treatment 147, 283-293, 2014
Mandates: US National Institutes of Health, Susan G. Komen
Targeting the nuclear export protein XPO1/CRM1 reverses epithelial to mesenchymal transition
AS Azmi, I Muqbil, J Wu, A Aboukameel, W Senapedis, E Baloglu, ...
Scientific reports 5 (1), 16077, 2015
Mandates: US National Institutes of Health
Fibroblast growth factor receptor 1 amplification in non-small cell lung cancer by quantitative real-time PCR
SM Gadgeel, W Chen, ML Cote, A Bollig-Fischer, S Land, AG Schwartz, ...
PLoS One 8 (11), e79820, 2013
Mandates: US National Institutes of Health
Obesity‐induced MBD 2_v2 expression promotes tumor‐initiating triple‐negative breast cancer stem cells
EA Teslow, C Mitrea, B Bao, RM Mohammad, LA Polin, G Dyson, ...
Molecular oncology 13 (4), 894-908, 2019
Mandates: US National Institutes of Health
The molecular genomics of metastatic brain tumours
A Bollig-Fischer, SK Michelhaugh, R Ali-Fehmi, S Mittal
OA molecular oncology 1 (1), 2013
Mandates: US National Institutes of Health
Role of TET1 and 5hmC in an obesity-linked pathway driving cancer stem cells in triple-negative breast cancer
B Bao, EA Teslow, C Mitrea, JL Boerner, G Dyson, A Bollig-Fischer
Molecular Cancer Research 18 (12), 1803-1814, 2020
Mandates: US National Institutes of Health
Systems analysis reveals a transcriptional reversal of the mesenchymal phenotype induced by SNAIL-inhibitor GN-25
AS Azmi, A Bollig-Fischer, B Bao, BJ Park, SH Lee, G Yong-Song, ...
BMC systems biology 7, 1-12, 2013
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program